A BILL 
To amend title XXVII of the Public Health Service Act 
to prohibit group health plans and health insurance 
issuers offering group or individual health insurance cov-
erage from imposing cost-sharing requirements or treat-
ment limitations with respect to diagnostic examinations 
for breast cancer that are less favorable than such re-
quirements with respect to screening examinations for 
breast cancer. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
04:21 Oct 29, 2021
H5769
2 
•HR 5769 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Access to Breast Can-
2
cer Diagnosis Act of 2021’’. 
3
SEC. 2. REQUIRING PARITY IN COST-SHARING AND TREAT-
4
MENT LIMITATIONS WITH RESPECT TO DIAG-
5
NOSTIC AND SCREENING EXAMINATIONS FOR 
6
BREAST CANCER. 
7
(a) IN GENERAL.—Subpart II of part A of title 
8
XXVII of the Public Health Service Act (42 U.S.C. 
9
300gg–11 et seq.) is amended by adding at the end the 
10
following new section: 
11
‘‘SEC. 2730. DIAGNOSTIC AND SCREENING EXAMINATIONS 
12
FOR BREAST CANCER PARITY. 
13
‘‘(a) IN GENERAL.—In the case of a group health 
14
plan, or a health insurance issuer offering group or indi-
15
vidual health insurance coverage, that provides benefits 
16
with respect to a diagnostic examination for breast cancer 
17
furnished to an individual enrolled under such plan or 
18
such coverage, such plan or such coverage shall ensure 
19
that— 
20
‘‘(1) the cost-sharing requirements applicable to 
21
such examination for such individual are no less fa-
22
vorable than such requirements applicable to a 
23
screening examination for breast cancer for such in-
24
dividual; and 
25
04:21 Oct 29, 2021
H5769
3 
•HR 5769 IH
‘‘(2) the treatment limitations applicable to 
1
such diagnostic examination for breast cancer for 
2
such individual are no less favorable than such limi-
3
tations applicable to a screening examinations for 
4
breast cancer for such individual. 
5
‘‘(b) RESTRICTION ON CERTAIN CHANGES.—A group 
6
health plan or health insurance issuer may not, for the 
7
sole purpose of complying with subsection (a), increase 
8
cost-sharing requirements with respect to screening exami-
9
nations for breast cancer. 
10
‘‘(c) CONSTRUCTION.—Nothing in this section shall 
11
be construed— 
12
‘‘(1) to require the use of diagnostic examina-
13
tions for breast cancer as a replacement for screen-
14
ing examinations for breast cancer; 
15
‘‘(2) to prohibit a group health plan or health 
16
insurance issuers from requiring prior authorization 
17
or imposing other appropriate utilization controls in 
18
approving coverage for any screening or diagnostic 
19
imaging; or 
20
‘‘(3) to supersede a State law that provides 
21
greater protections with respect to the coverage of 
22
diagnostic examinations for breast cancer than is 
23
provided under this subsection. 
24
‘‘(d) DEFINITIONS.—In this section: 
25
04:21 Oct 29, 2021
H5769
4 
•HR 5769 IH
‘‘(1) COST-SHARING REQUIREMENT.—The term 
1
‘cost-sharing requirement’ includes a deductible, co-
2
insurance, copayment, and any maximum limitation 
3
on the application of such a deductible, coinsurance, 
4
copayment, or similar out-of-pocket expense. 
5
‘‘(2) DIAGNOSTIC
EXAMINATION
FOR
BREAST 
6
CANCER.—The term ‘diagnostic examination for 
7
breast cancer’ means a medically necessary and ap-
8
propriate (as determined by the health care profes-
9
sional treating the individual) examination for breast 
10
cancer to evaluate an abnormality in the breast that 
11
is— 
12
‘‘(A) seen or suspected from a screening 
13
examination for breast cancer; 
14
‘‘(B) detected by another means of exam-
15
ination; or 
16
‘‘(C) suspected based on the medical his-
17
tory or family medical history of the individual. 
18
‘‘(3) EXAMINATION FOR BREAST CANCER.—The 
19
term ‘examination for breast cancer’ includes such 
20
an examination using breast ultrasound, breast mag-
21
netic resonance imaging, or mammography. 
22
‘‘(4) 
TREATMENT
LIMITATION.—The 
term 
23
‘treatment limitation’ includes limits on the fre-
24
quency of treatment, number of visits, days of cov-
25
04:21 Oct 29, 2021
H5769
5 
•HR 5769 IH
erage, or other similar limits on the scope or dura-
1
tion of treatment.’’. 
2
(b) APPLICATION
TO GRANDFATHERED HEALTH 
3
PLANS.—Section 1251(a)(4)(A) of the Patient Protection 
4
and Affordable Care Act (42 U.S.C. 18011(a)(4)(A)) is 
5
amended— 
6
(1) by striking ‘‘title’’ and inserting ‘‘title, or as 
7
added after the date of the enactment of this Act)’’; 
8
and 
9
(2) by adding at the end the following new 
10
clause: 
11
‘‘(v) Section 2730 (relating to parity 
12
for diagnostic and screening examinations 
13
for breast cancer).’’. 
14
(c) EFFECTIVE DATE.—The amendments made by 
15
this section shall apply with respect to plan years begin-
16
ning on or after January 1, 2022. 
17
Æ 
04:21 Oct 29, 2021
H5769
